Live Breaking News & Updates on Melissa Tosca

Stay updated with breaking news from Melissa tosca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences

Kiora Pharmaceuticals, Inc. , will participate in two upcoming investor conferences that will be available to investors live with the replay available on-demand. On Wednesday May 22, at 3:00 pm. ....

Brian Strem , California Newsfile Corp , Kiora Pharmaceuticals , Kiora Pharmaceuticals Inc , Wednesday May , Eastern Time , Executive Vice President , Melissa Tosca , Webull Corporate Connect Biotech Investment , Lytham Partners Spring , Lytham Partners ,

Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease

Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Brianm Strem , University Of California , Kiora Pharmaceuticals , Kiora Pharmaceuticals Inc , Association Of Research , California Newsfile Corp , Open Innovation , Melissa Tosca , Investigational New Drug , Initiate Phase , Private Securities Litigation Reform Act , Annual Report , Current Assets , Release Assets , Current Liabilities , Months Ended March , Fair Value , Common Share , Average Shares Outstanding , Comprehensive Income ,

Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases

Kiora Pharmaceuticals, Inc. today announced its 2023 financial results and provided an update on its retinal disease development pipeline. The Company s major initiatives planned for 2024 are to. ....

Brianm Strem , California Newsfile Corp , Kiora Pharmaceuticals Inc , Kiora Pharmaceuticals , Open Innovation , Melissa Tosca , Upcoming Milestones , Orphan Drug Designations , Private Securities Litigation Reform Act , Annual Report ,

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Brianm Strem , Dennis Riedl , Kiora Pharmaceuticals Inc , California Newsfile Corp , Kiora Pharmaceuticals , Open Innovation , Melissa Tosca , Upcoming Milestones , Orphan Drug Designations , Private Securities Litigation Reform Act , Annual Report ,

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Provides 3rd Quarter 2022 Business and Financial Update; Dosing of KIO-301 in Phase 1 Trial for Retinitis Pigmentosa to Begin Before Year's End

Salt Lake City, Utah (Newsfile Corp. - November 9, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today is providing a business update and reporting financial results ....

New South Wales , Salt Lake City , United States , Francina Agosti , Eric Daniels , Brianm Strem , Utah Newsfile Corp , Kiora Pharmaceuticals , Kiora Pharmaceuticals Inc , Chief Executive Officer , Retinitis Pigmentosa , Persistent Corneal Epithelial Defects , Rheumatoid Arthritis , Persistent Corneal Epithelial , Melissa Tosca , Executive Vice President , Ocular Presentation , Dihydroorotate Dehydrogenase , Private Securities Litigation Reform Act , Annual Report ,